June 13, 2024

Animal Model Market Size to Attain USD 5.72 Billion by 2033

The global animal model market size accounted for US$ 2.48 billion in 2023 and is projected to reach around USD 5.72 billion by 2033, growing at a CAGR of 8.71% from 2024 to 2033.

Animal Model Market Size 2024 to 2033

Key Points

  • North America led the market with the largest market share of 50% in 2023.
  • By application type, the cancer segment has held the largest market share of 44% in 2023.
  • By animal type, the mice & rat segment held the largest share of 53% in 2023.
  • By end use, in 2023, the pharmaceutical & biotechnology companies segment has captured more than 40% of market share in 2023.

Report Summary

The global animal model market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.

The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the animal model market across the globe.

A comprehensive estimate on the animal model market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of animal model during the forecast period. Price point comparison by region with global average price is also considered in the study.

Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/3890

Animal Model Market Scope

Report Coverage Details
Growth Rate from 2024 to 2033 CAGR of 8.71%
Global Market Size in 2023 USD 2.48 Billion
Global Market Size by 2033 USD 5.72 Billion
U.S. Market Size in 2023 USD 0.93 Billion
U.S. Market Size by 2033 USD 2.15 Billion
Base Year 2023
Forecast Period 2024 to 2033
Segments Covered By Application, By Animal Type, and By End-use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Key Highlights:

Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized animal model market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.

Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.

Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.

Also Read: Recombinant Antibodies Market Size to Cross USD 23.34 Bn by 2033

Market Players

The report includes the profiles of key animal model market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.

Recent Developments

  • In September 2022, Solid Biosciences announced its acquisition of AavantiBio alongside a concurrent $75 million private placement.
  • In April 2023, Merck bolstered its immunology pipeline with the acquisition of Prometheus Biosciences, Inc.
  • In February 2023, AstraZeneca successfully completed the acquisition of CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company focused on developing novel treatments for resistant and uncontrolled hypertension as well as chronic kidney disease.
  • In August 2023, Biocytogen established two business divisions to distinguish preclinical models and Services (BioMice) from antibody-drug R&D.

Animal Model Market Companies

  • Charles River Laboratories
  • The Jackson Laboratory
  • genOway
  • Taconic Biosciences, Inc.
  • Janvier Labs
  • Harbour BioMed
  • Crown Bioscience
  • Inotiv
  • BIOCYTOGEN
  • BioSpherix, Ltd.

Segments Covered in the Report

By Application

  • Cancer
  • Immunological Disease
  • Infectious Disease
  • Others

By Animal Type

  • Mice
  • Rat
  • Guinea Pigs
  • Rabbits
  • Hamsters
  • Others

By End-use

  • Pharmaceutical & Biotechnology Companies
  • Academic Research Institute
  • Contract Research Organization

Regional Segmentation

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Research Methodology

Secondary Research

It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.

The secondary research sources referred in the process are as follows:

  • Governmental bodies, and organizations creating economic policies
  • National and international social welfare institutions
  • Company websites, financial reports and SEC filings, broker and investor reports
  • Related patent and regulatory databases
  • Statistical databases and market reports
  • Corporate Presentations, news, press release, and specification sheet of Manufacturers

Primary Research

Primary research includes face-to-face interviews, online surveys, and telephonic interviews.

  • Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
  • In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Animal Model Market 

5.1. COVID-19 Landscape: Animal Model Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Animal Model Market, By Application

8.1. Animal Model Market, by Application, 2024-2033

8.1.1 Cancer

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Immunological Disease

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Infectious Disease

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Others

8.1.4.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Animal Model Market, By Animal Type

9.1. Animal Model Market, by Animal Type, 2024-2033

9.1.1. Mice

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Rat

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Guinea Pigs

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Rabbits

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Hamsters

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.6. Others

9.1.6.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Animal Model Market, By End-use 

10.1. Animal Model Market, by End-use, 2024-2033

10.1.1. Pharmaceutical & Biotechnology Companies

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Academic Research Institute

10.1.2.1. Market Revenue and Forecast (2021-2033)

10.1.3. Contract Research Organization

10.1.3.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Animal Model Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.1.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.2.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.3.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.6.3. Market Revenue and Forecast, by End-use (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Application (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.4.7.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.4.3. Market Revenue and Forecast, by End-use (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Application (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Animal Type (2021-2033)

11.5.5.3. Market Revenue and Forecast, by End-use (2021-2033)

Chapter 12. Company Profiles

12.1. Charles River Laboratories

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. The Jackson Laboratory

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. genOway

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Taconic Biosciences, Inc.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Janvier Labs

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Harbour BioMed

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Crown Bioscience

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Inotiv

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. BIOCYTOGEN

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. BioSpherix, Ltd.

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Emailsales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.pharma-geek.com


Prathamesh

Leave a Reply

Your email address will not be published. Required fields are marked *